Cargando…

Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids

This review is devoted to modern systems of nanocarriers that ensure the targeted delivery of flavonoids to various organs and systems. Flavonoids have wide range of effects on the human body due to their antioxidant, anti-inflammatory, antitumor, antimicrobial, antiplatelet and other types of activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zverev, Ya. F., Rykunova, A. Ya.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756931/
https://www.ncbi.nlm.nih.gov/pubmed/36540406
http://dx.doi.org/10.1134/S0003683822090149
_version_ 1784851722809638912
author Zverev, Ya. F.
Rykunova, A. Ya.
author_facet Zverev, Ya. F.
Rykunova, A. Ya.
author_sort Zverev, Ya. F.
collection PubMed
description This review is devoted to modern systems of nanocarriers that ensure the targeted delivery of flavonoids to various organs and systems. Flavonoids have wide range of effects on the human body due to their antioxidant, anti-inflammatory, antitumor, antimicrobial, antiplatelet and other types of activity. However, the low bioavailability of flavonoids significantly limits their practical application. To overcome this disadvantage, serious efforts have been made in recent years to develop nanoscale carriers for flavonoids. This is particularly important in view of the known antitumor effect of these compounds, which allows them to target tumor cells without affecting surrounding healthy tissues. Nanocarriers provide increased penetration of biologicals into specific organs in combination with controlled and prolonged release, which markedly improves their effectiveness. This review summarizes data on the use of phytosomes, lipid-based nanoparticles, as well as polymeric and inorganic nanoparticles; their advantages and drawbacks are analyzed; the prospect of their use is discussed that opens new possibilities for the clinical application of flavonoids.
format Online
Article
Text
id pubmed-9756931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pleiades Publishing
record_format MEDLINE/PubMed
spelling pubmed-97569312022-12-16 Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids Zverev, Ya. F. Rykunova, A. Ya. Appl Biochem Microbiol Medical Biotechnology This review is devoted to modern systems of nanocarriers that ensure the targeted delivery of flavonoids to various organs and systems. Flavonoids have wide range of effects on the human body due to their antioxidant, anti-inflammatory, antitumor, antimicrobial, antiplatelet and other types of activity. However, the low bioavailability of flavonoids significantly limits their practical application. To overcome this disadvantage, serious efforts have been made in recent years to develop nanoscale carriers for flavonoids. This is particularly important in view of the known antitumor effect of these compounds, which allows them to target tumor cells without affecting surrounding healthy tissues. Nanocarriers provide increased penetration of biologicals into specific organs in combination with controlled and prolonged release, which markedly improves their effectiveness. This review summarizes data on the use of phytosomes, lipid-based nanoparticles, as well as polymeric and inorganic nanoparticles; their advantages and drawbacks are analyzed; the prospect of their use is discussed that opens new possibilities for the clinical application of flavonoids. Pleiades Publishing 2022-12-16 2022 /pmc/articles/PMC9756931/ /pubmed/36540406 http://dx.doi.org/10.1134/S0003683822090149 Text en © Pleiades Publishing, Inc. 2022, ISSN 0003-6838, Applied Biochemistry and Microbiology, 2022, Vol. 58, No. 9, pp. 1002–1020. © Pleiades Publishing, Inc., 2022.Russian Text © The Author(s), 2022, published in Biotekhnologiya, 2022, Vol. 38, No. 1, pp. 47–68. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Medical Biotechnology
Zverev, Ya. F.
Rykunova, A. Ya.
Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title_full Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title_fullStr Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title_full_unstemmed Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title_short Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids
title_sort modern nanocarriers as a factor in increasing the bioavailability and pharmacological activity of flavonoids
topic Medical Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756931/
https://www.ncbi.nlm.nih.gov/pubmed/36540406
http://dx.doi.org/10.1134/S0003683822090149
work_keys_str_mv AT zverevyaf modernnanocarriersasafactorinincreasingthebioavailabilityandpharmacologicalactivityofflavonoids
AT rykunovaaya modernnanocarriersasafactorinincreasingthebioavailabilityandpharmacologicalactivityofflavonoids